BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

659 related articles for article (PubMed ID: 17971459)

  • 1. Efficient management of rheumatoid arthritis significantly reduces long-term functional disability.
    Tanaka E; Mannalithara A; Inoue E; Hara M; Tomatsu T; Kamatani N; Singh G; Yamanaka H
    Ann Rheum Dis; 2008 Aug; 67(8):1153-8. PubMed ID: 17971459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is the disease course of rheumatoid arthritis becoming milder? Time trends since 1985 in an inception cohort of early rheumatoid arthritis.
    Welsing PM; Fransen J; van Riel PL
    Arthritis Rheum; 2005 Sep; 52(9):2616-24. PubMed ID: 16142762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiographic damage in rheumatoid arthritis correlates with functional disability but not direct medical costs.
    Clarke AE; St-Pierre Y; Joseph L; Penrod J; Sibley JT; Haga M; Genant HK
    J Rheumatol; 2001 Nov; 28(11):2416-24. PubMed ID: 11708412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of sex on rheumatoid arthritis: a prospective study of onset and outcome after 2 years.
    Tengstrand B; Ahlmén M; Hafström I
    J Rheumatol; 2004 Feb; 31(2):214-22. PubMed ID: 14760787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The methotrexate therapeutic response in rheumatoid arthritis.
    Ortendahl M; Holmes T; Schettler JD; Fries JF
    J Rheumatol; 2002 Oct; 29(10):2084-91. PubMed ID: 12375316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A reappraisal of HAQ disability in rheumatoid arthritis.
    Wolfe F
    Arthritis Rheum; 2000 Dec; 43(12):2751-61. PubMed ID: 11145033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determining rheumatologists' accuracy at assessing functional disability in rheumatoid arthritis patients using the Health Assessment Questionnaire-Disability Index.
    Carter JD; Lodhi AB; Nagda SR; Ricca L; Ward C; Traina E; Thompson ZJ; Huang Y; Valeriano J; Vasey FB
    J Rheumatol; 2007 May; 34(5):958-63. PubMed ID: 17407221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of a Japanese version of the Stanford Health Assessment Questionnaire in 3,763 patients with rheumatoid arthritis.
    Matsuda Y; Singh G; Yamanaka H; Tanaka E; Urano W; Taniguchi A; Saito T; Hara M; Tomatsu T; Kamatani N
    Arthritis Rheum; 2003 Dec; 49(6):784-8. PubMed ID: 14673964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The patient's perspective and rheumatoid arthritis disease activity indexes.
    Leeb BF; Andel I; Leder S; Leeb BA; Rintelen B
    Rheumatology (Oxford); 2005 Mar; 44(3):360-5. PubMed ID: 15572395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A 10 year prospective followup of patients with rheumatoid arthritis 1986-96.
    Gordon P; West J; Jones H; Gibson T
    J Rheumatol; 2001 Nov; 28(11):2409-15. PubMed ID: 11708411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Etanercept (Enbrel) in patients with rheumatoid arthritis with recent onset versus established disease: improvement in disability.
    Baumgartner SW; Fleischmann RM; Moreland LW; Schiff MH; Markenson J; Whitmore JB
    J Rheumatol; 2004 Aug; 31(8):1532-7. PubMed ID: 15290731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High dose chemotherapy and hematopoietic stem cell transplantation: a study of treatment preference in patients with rheumatoid arthritis and rheumatologists.
    Verburg RJ; Mahabali SD; Stiggelbout AM; Sont JK; van Laar JM
    J Rheumatol; 2002 Aug; 29(8):1653-8. PubMed ID: 12180724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "5D" Outcome in 52 patients with rheumatoid arthritis surviving 20 years after initial disease modifying antirheumatic drug therapy.
    Capell H; McCarey D; Madhok R; Hampson R
    J Rheumatol; 2002 Oct; 29(10):2099-105. PubMed ID: 12375318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What factors influence functional ability in patients with rheumatoid arthritis. Do they alter over time?
    Plant MJ; O'Sullivan MM; Lewis PA; Camilleri JP; Coles EC; Jessop JD
    Rheumatology (Oxford); 2005 Sep; 44(9):1181-5. PubMed ID: 15972357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in Health Assessment Questionnaire disability scores over five years in patients with rheumatoid arthritis compared with the general population.
    Sokka T; Kautiainen H; Hannonen P; Pincus T
    Arthritis Rheum; 2006 Oct; 54(10):3113-8. PubMed ID: 17009231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing utility values in rheumatoid arthritis: a comparison between time trade-off and the EuroQol.
    Ariza-Ariza R; Hernández-Cruz B; Carmona L; Dolores Ruiz-Montesinos M; Ballina J; Navarro-Sarabia F;
    Arthritis Rheum; 2006 Oct; 55(5):751-6. PubMed ID: 17013822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between disease activity, joint destruction, and functional capacity over the course of rheumatoid arthritis.
    Welsing PM; van Gestel AM; Swinkels HL; Kiemeney LA; van Riel PL
    Arthritis Rheum; 2001 Sep; 44(9):2009-17. PubMed ID: 11592361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Disease Activity Score in 28 joints in rheumatoid arthritis and psoriatic arthritis patients.
    Leeb BF; Andel I; Sautner J; Fassl C; Nothnagl T; Rintelen B
    Arthritis Rheum; 2007 Mar; 57(2):256-60. PubMed ID: 17330303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Reliability and validition of the Slovak modified version of the Stanford Health Assessment Questionnaire using the functional disability index in patients with rheumatoid arthritis].
    Szilasiová A; Macejová Z; Nagyová I; Kovarová M; Béresová A; Szilasiová J
    Vnitr Lek; 2002 Jan; 48(1):8-16. PubMed ID: 11852593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term outcome after anti-tumor necrosis factor-alpha therapy in rheumatoid arthritis: do we need to revise our assessment criteria?
    El Miedany Y; Youssef SS; El Gaafary M
    J Rheumatol; 2006 Mar; 33(3):490-7. PubMed ID: 16511918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.